Purine Nucleoside Phosphorylase Deficiency
Robert L. Wortmann(Medical College of Wisconsin), Irving H. Fox(Takeda (United States)), Erwin W. Gelfand(National Jewish Health), Kenneth Rich(University of Illinois Chicago), Edwin Mejías, William N. Arnold(Community Health Systems - Lutheran Hospital), Catherine M. Andres(University of Michigan)
Cited by 26
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
|Gastroenterology|2014|714
Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin
|New England Journal of Medicine|2005|694